Materion Corporation (MTRN)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents US$ in thousands 13,294 16,401 16,574 15,243 13,101 20,682 32,175 20,237 14,462 18,009 24,345 18,934 25,878 117,754 265,068 107,576 125,007 94,526 74,856 41,864
Short-term investments US$ in thousands 5,047 4,922 3,725 2,798 1,329
Total current liabilities US$ in thousands 254,995 217,205 233,250 245,817 238,964 202,290 210,225 201,461 204,509 172,769 161,227 147,435 126,884 251,626 268,528 113,670 122,440 126,975 125,037 131,156
Cash ratio 0.05 0.10 0.09 0.08 0.05 0.12 0.16 0.10 0.07 0.10 0.15 0.13 0.20 0.47 0.99 0.95 1.02 0.74 0.60 0.32

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($13,294K + $—K) ÷ $254,995K
= 0.05

The cash ratio of Materion Corp has shown fluctuations over the past eight quarters, ranging from 0.22 to 0.33. The cash ratio measures a company's ability to cover its short-term obligations with its cash and cash equivalents. A higher cash ratio indicates a stronger ability to cover these obligations.

In Q3 2023, the cash ratio was 0.33, reflecting an increase from the previous quarter, indicating that Materion had more cash and cash equivalents relative to its current liabilities. However, in Q2 2023, the ratio decreased to 0.23, suggesting a potential decrease in liquidity compared to Q3 2023.

Overall, the company's cash ratio has remained relatively stable between 0.22 and 0.33 over the past two years, indicating that Materion has maintained a consistent level of liquidity to cover its short-term obligations. It is important for investors and analysts to continue monitoring Materion's cash ratio to assess the company's liquidity position and ability to meet its short-term financial commitments.